India has a high percentage of diabetics, and the overconsumption of sugar remains socially acceptable. Sugar is ubiquitous, found in almost everything we consume. The consumption of added sugars has been linked to chronic diseases. Investigations have revealed that baby food produced by Nestle has added sugar in lower-income countries like India. Europe has stricter food regulations concerning sugar. The article stresses the need for stronger regulations, mindfulness in consumption, and the importance of reading food labels.
Novo Nordisk’s oral semaglutide tablet, known as Rybelsus, is gaining popularity in India for treating diabetes and weight reduction. Sales of the drug have more than doubled in the past year. However, doctors have advised against indiscriminate use of the drug. The success of Rybelsus has led to a tripled anti-obesity market in India.